OraSure Technologies Inc OSUR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OSUR is a good fit for your portfolio.
News
-
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
-
OraSure Technologies Supports National HIV Testing Day
-
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
-
OraSure Reports Q1 ’24 Revenue of $54.1 Million
Trading Information
- Previous Close Price
- $4.38
- Day Range
- $4.30–4.43
- 52-Week Range
- $3.92–8.43
- Bid/Ask
- $4.31 / $4.32
- Market Cap
- $319.50 Mil
- Volume/Avg
- 724,755 / 1.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 6.96
- Price/Sales
- 1.05
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.68%
Company Profile
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 638
- Website
- https://www.orasure.com
Comparables
Valuation
|
Metric
|
OSUR
|
NEO
|
SRDX
|
|---|---|---|---|
Price/Earnings (Normalized) | 6.96 | — | 37.00 |
Price/Book Value | 0.75 | 2.05 | 4.77 |
Price/Sales | 1.05 | 3.06 | 4.08 |
Price/Cash Flow | 4.83 | 62.38 | 19.50 |
Price/Earnings
OSUR
NEO
SRDX
Financial Strength
|
Metric
|
OSUR
|
NEO
|
SRDX
|
|---|---|---|---|
Quick Ratio | 10.23 | 6.85 | 3.40 |
Current Ratio | 11.97 | 7.48 | 4.39 |
Interest Coverage | — | — | 5.87 |
Quick Ratio
OSUR
NEO
SRDX
Profitability
|
Metric
|
OSUR
|
NEO
|
SRDX
|
|---|---|---|---|
Return on Assets (Normalized) | 9.93% | −0.34% | 8.80% |
Return on Equity (Normalized) | 11.25% | −0.60% | 13.69% |
Return on Invested Capital (Normalized) | 10.88% | −1.06% | 12.48% |
Return on Assets
OSUR
NEO
SRDX
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Jhycnmvsz | Ffgn | $156.8 Bil | |||
| Becton Dickinson & Co
BDX
| Nbhjmsl | Ykzhn | $68.6 Bil | |||
| Alcon Inc
ALC
| Vybdbssv | Mjkpf | $46.5 Bil | |||
| Coloplast A/S ADR
CLPBY
| Jbnwwwxgq | Llcxp | $29.1 Bil | |||
| ResMed Inc
RMD
| Bvnwxvppj | Sskgrq | $28.9 Bil | |||
| West Pharmaceutical Services Inc
WST
| Krgrdqrby | Tydxp | $20.7 Bil | |||
| The Cooper Companies Inc
COO
| Hghfqlqc | Vkmnxn | $18.6 Bil | |||
| Hologic Inc
HOLX
| Wswrsnsqz | Zrsjs | $18.4 Bil | |||
| Baxter International Inc
BAX
| Yqdqyymd | Zvszh | $18.1 Bil | |||
| Teleflex Inc
TFX
| Rlll | Fhtfr | $10.4 Bil |